Trial Profile
Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Anaesthesia; Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 19 Mar 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 02 Dec 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 02 Dec 2014 Planned End Date changed from 1 Feb 2015 to 1 May 2015 as per ClinicalTrials.gov record.